Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Convertible Debt: 2012-2019

  • CorMedix's Convertible Debt was N/A to $6.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $6.7 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2018, which is N/A change from last year.
  • According to the latest figures from Q2 2019, CorMedix's Convertible Debt is $6.7 million, which was up 4.77% from $6.4 million recorded in Q1 2019.
  • CorMedix's 5-year Convertible Debt high stood at $6.7 million for Q2 2019, and its period low was $6.1 million during Q4 2018.
  • For the 2-year period, CorMedix's Convertible Debt averaged around $6.4 million, with its median value being $6.4 million (2019).